We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANDA SETTLEMENTS MUST BE REPORTED BEFORE DRUG CAN BE MARKETED
ANDA SETTLEMENTS MUST BE REPORTED BEFORE DRUG CAN BE MARKETED
January 7, 2004
Pharmaceutical firms must now inform federal antitrust watchdogs when they settle disputes over the launch of generic versions of brand drugs. The Federal Trade Commission (FTC) yesterday published a reminder to drugmakers that they have only 10 business days after reaching an agreement to file a copy with the commission and the Justice Department.